USPTO 2015–2025 USPTO PatentsView Foreign Corporation

IP2IPO Innovations Limited

USPTO PatentsView assignee record — 48 granted patents across 52 technology areas, active 2019–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

48
Total patents granted
52
CPC technology areas
16.8
Avg claims per patent
+600%
5-year filing velocity

Portfolio overview

IP2IPO Innovations Limited has been granted 48 US utility patents between 2019 and 2025, placing IP2IPO Innovations Limited at rank #6,905 across all assignees tracked by PlainPatent. This portfolio spans 52 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, IP2IPO Innovations Limited is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 54.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 42 grants, compared with 6 in the 2015–2019 window — a +600% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. IP2IPO Innovations Limited's 16.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 52 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark IP2IPO Innovations Limited against peers pursuing similar technology classes.

How does IP2IPO compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows IP2IPO holds 48 patents — placing it at rank #6,905 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2019–2025

051015 2019202020212022202320242025 1
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
IP2IPO Innovations Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 6 12.5%
2020 5 10.4%
2021 13 27.1%
2022 10 20.8%
2023 6 12.5%
2024 7 14.6%
2025 1 2.1%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#6,905

Across all tracked assignees

Innovation Score

54.9 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does IP2IPO Innovations Limited hold?
IP2IPO Innovations Limited holds 48 US granted patents filed between 2019 and 2025, spanning 52 technology areas.
What is IP2IPO Innovations Limited's Innovation Score?
IP2IPO Innovations Limited has an Innovation Score of 54.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does IP2IPO Innovations Limited focus on?
IP2IPO Innovations Limited's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 13 patents. The company has filed patents in 52 CPC subclasses total.
Is IP2IPO Innovations Limited's patent filing rate increasing or decreasing?
IP2IPO Innovations Limited's recent filing velocity is +600% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for IP2IPO Innovations Limited's patents?
IP2IPO Innovations Limited's patents average 16.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the IP2IPO Innovations Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope